BRKIX
Price
$17.71
Change
+$0.09 (+0.51%)
Updated
Sep 17 closing price
Net Assets
113.31M
RNWAX
Price
$90.32
Change
+$0.03 (+0.03%)
Updated
Sep 17 closing price
Net Assets
74.08B
Interact to see
Advertisement

BRKIX vs RNWAX

Header iconBRKIX vs RNWAX Comparison
Open Charts BRKIX vs RNWAXBanner chart's image
MFS Blended Research Em Mkts Eq I
Price$17.71
Change+$0.09 (+0.51%)
VolumeN/A
Net Assets113.31M
American Funds New World R1
Price$90.32
Change+$0.03 (+0.03%)
VolumeN/A
Net Assets74.08B
BRKIX vs RNWAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BRKIX vs. RNWAX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRKIX is a Buy and RNWAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWAX has more cash in the bank: 74.1B vs. BRKIX (113M). BRKIX pays higher dividends than RNWAX: BRKIX (2.09) vs RNWAX (0.00). BRKIX was incepted earlier than RNWAX: BRKIX (10 years) vs RNWAX (23 years). BRKIX (1.70) and RNWAX (1.66) have similar cost to investors . BRKIX is a more actively managed with annual turnover of: 58.00 vs. RNWAX (37.00). BRKIX has a lower initial minimum investment than RNWAX: BRKIX (0) vs RNWAX (250). BRKIX annual gain was more profitable for investors over the last year : 28.33 vs. RNWAX (15.82). BRKIX return over 5 years is better than : 48.82 vs. RNWAX (26.96).
BRKIXRNWAXBRKIX / RNWAX
Total Expense Ratio0.991.6660%
Annual Report Gross Expense Ratio1.701.66102%
Fund Existence10 years23 years-
Gain YTD27.86622.667123%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets113M74.1B0%
Annual Yield % from dividends2.090.00-
Returns for 1 year28.3315.82179%
Returns for 3 years59.7946.83128%
Returns for 5 years48.8226.96181%
Returns for 10 years101.2789.58113%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNTH38.841.37
+3.66%
Dianthus Therapeutics
FERAU10.50N/A
N/A
Fifth Era Acquisition Corp I
SIMA10.46N/A
N/A
SIM Acquisition Corp I
STVN26.93-0.30
-1.10%
Stevanato Group SpA
CPIX3.23-0.13
-3.87%
Cumberland Pharmaceuticals